ALEXANDRA ROSSI: Open Payments
NPI 1538892468 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,697 in 65 payments from 5 companies in 2025. Trend: 2023 $379 · 2024 $2,317 · 2025 $30,697
Speaker / faculty: $13,088Consulting: $8,320Travel & lodging: $6,938Food & beverage: $2,342Education: $10
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 43 | $20,539 |
| Novartis Pharmaceuticals Corporation | 8 | $5,095 |
| EMD Serono, Inc. | 11 | $4,967 |
| Genentech USA, Inc. | 2 | $51 |
| GENZYME CORPORATION | 1 | $44 |
Products named: BRIUMVI, KESIMPTA, Mavenclad, Ocrevus Zunovo.
Industry payments across TX — which companies pay providers there.
